Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of Genotypic Resistance Guided Versus Susceptibility Testing Guided Therapy for the Third-line Eradication of H. Pylori- a Multicenter Randomized Trial

NCT03555526 is registered in ClinicalTrials.gov with National Taiwan University Hospital as lead sponsor.

NCT NCT03555526
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03555526 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of Genotypic Resistance Guided Versus Susceptibility Testing Guided Therapy for the Third-line Eradication of H. Pylori- a Multicenter Randomized Trial
Lead sponsor
National Taiwan University Hospital
Phase
Phase 4
Overall status
Unknown status
Start date
December 15, 2017
Completion date
December 31, 2021
Enrollment
320 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

h pylori infection